Rexahn Completes Patient Enrollment in Phase IIa Clinical Trial of ZoraxelTM to Treat Erectile Dysfunction Jan 26, 2009
Rexahn Pharmaceuticals Strengthens Clinical Development Leadership with Formation of Oncology Scientific Advisory Board Nov 17, 2008
Rexahn Pharmaceuticals Receives FDA Approval to Initiate Phase II Trial for Serdaxin in Patients with Major Depressive Disorders Sep 10, 2008